chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Computerised tomogram head normal, Computerised tomogram thorax normal, Culture urine negative, Depressed level of consciousness
Clinical narrative: Patient is a 65 y.o. male patient of MD.   Report on admission: This is a 65-year-old male with severe mental retardation and is nonverbal presenting to the emergency department for altered mental status.  Caregiver at the bedside reports that this morning when they tried to get him up he did not want to open his eyes.  She states that he did not want to take his medication and usually he is very good about it.  EMS was called and he was noted to have a blood sugar of 55.  He was given D50 and seems to be more responsive.  Blood sugar at the recheck is over 200.  Upon arrival to the emergency department he is noted to have a blood pressure in the 60s.  Hospital course as below.  Patient improved with medical treatment.  Patient discharged back to group home in stable condition.     1.  COVID, + 12/25/2022: -CT chest without pneumonia -Decadron -Patient back on room air, no indication remdesivir -Lovenox DVT prophylaxis  2.  Acute hypoxic respiratory failure: Resolved -Secondary to above -Wean oxygen as able  3.  Elevated troponin: -Cardiology consulted -ACS ruled out -No further work-up at this time  4.  AKI: Resolved -Monitor labs  5.  Sepsis trigger: -Received broad-spectrum antibiotics in ER -12/25 blood cultures no growth to date -Urine culture negative -Monitor off antibiotics  6.  Acute encephalopathy: -CT head nonacute  7.  Other chronic medical conditions: History of anemia, known aortic aneurysm, bladder incontinence, history depression, nonverbal, OCD, history of seizure, mental retardation
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Encephalopathy, Mental status changes, SARS-CoV-2 test positive, Sepsis, Troponin increased
Clinical narrative: Patient is a 65 y.o. male patient of MD.   Report on admission: This is a 65-year-old male with severe mental retardation and is nonverbal presenting to the emergency department for altered mental status.  Caregiver at the bedside reports that this morning when they tried to get him up he did not want to open his eyes.  She states that he did not want to take his medication and usually he is very good about it.  EMS was called and he was noted to have a blood sugar of 55.  He was given D50 and seems to be more responsive.  Blood sugar at the recheck is over 200.  Upon arrival to the emergency department he is noted to have a blood pressure in the 60s.  Hospital course as below.  Patient improved with medical treatment.  Patient discharged back to group home in stable condition.     1.  COVID, + 12/25/2022: -CT chest without pneumonia -Decadron -Patient back on room air, no indication remdesivir -Lovenox DVT prophylaxis  2.  Acute hypoxic respiratory failure: Resolved -Secondary to above -Wean oxygen as able  3.  Elevated troponin: -Cardiology consulted -ACS ruled out -No further work-up at this time  4.  AKI: Resolved -Monitor labs  5.  Sepsis trigger: -Received broad-spectrum antibiotics in ER -12/25 blood cultures no growth to date -Urine culture negative -Monitor off antibiotics  6.  Acute encephalopathy: -CT head nonacute  7.  Other chronic medical conditions: History of anemia, known aortic aneurysm, bladder incontinence, history depression, nonverbal, OCD, history of seizure, mental retardation
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Dry skin, Erythema, Formication, Headache
Clinical narrative: My left hand you can see the blue veins from the top of arm to my hands. 2 fingers had a red spot and in the middle of my knuckles and pinky finger had red spot. My left hand got so rough I can almost cut my face with my hand. I've been feeling tingly and crawling. I can't figure out what's going on.  It's still going on. It usually gets worse and worse. With headaches on the left side of my head. Breast swellingl on my 2nd reaction. They were swollen by the size of eggs.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Mammogram, Paraesthesia
Clinical narrative: My left hand you can see the blue veins from the top of arm to my hands. 2 fingers had a red spot and in the middle of my knuckles and pinky finger had red spot. My left hand got so rough I can almost cut my face with my hand. I've been feeling tingly and crawling. I can't figure out what's going on.  It's still going on. It usually gets worse and worse. With headaches on the left side of my head. Breast swellingl on my 2nd reaction. They were swollen by the size of eggs.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anuria, COVID-19, Chest X-ray abnormal, Condition aggravated
Clinical narrative: The patient is a 68 y.o. female with history of ESRD, DM 2, bipolar 1, asthma, anemia, HTN, schizoaffective schizophrenia, presented to the medical center with cough.   Acute hypoxic respiratory failure Covid-19 Virus Infection Date of onset of symptoms: 12/9 Symptoms present on admission: Cough, shortness of breath Date of covid positive test: 12/12 Vaccination status: vaccinated Imaging: CXR shows pulmonary vascularcongestion Oxygen requirements on admission: Room air Current oxygen requirements: RA saturating 94-95% Medical therapy: Decadron x 10 days Anticipated special isolation end date: 12/20 if afebrile off antipyretics (not a candidate for short isolation as symptoms are not improving)    ESRD Pulmonary vascular congestion Hyperkalemia Is compliant with HD, most recent HD on day of admission Typically receives HD on T/R/S Patient is anuric, pulm vascular congestion will be best managed by HD Consult Nephro, s/p HD 12/17   Poorly controlled hypertension BP as high as 213/90 Resume home meds As needed labetalol and hydralazine Outpatient follow-up   Anemia of chronic disease At baseline No active bleeding Monitor   Hyperlipidemia Continue statin   Schizoaffective disorder Continue Cogentin   GERD PPI
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Gastrooesophageal reflux disease, Haemodialysis, Hyperkalaemia
Clinical narrative: The patient is a 68 y.o. female with history of ESRD, DM 2, bipolar 1, asthma, anemia, HTN, schizoaffective schizophrenia, presented to the medical center with cough.   Acute hypoxic respiratory failure Covid-19 Virus Infection Date of onset of symptoms: 12/9 Symptoms present on admission: Cough, shortness of breath Date of covid positive test: 12/12 Vaccination status: vaccinated Imaging: CXR shows pulmonary vascularcongestion Oxygen requirements on admission: Room air Current oxygen requirements: RA saturating 94-95% Medical therapy: Decadron x 10 days Anticipated special isolation end date: 12/20 if afebrile off antipyretics (not a candidate for short isolation as symptoms are not improving)    ESRD Pulmonary vascular congestion Hyperkalemia Is compliant with HD, most recent HD on day of admission Typically receives HD on T/R/S Patient is anuric, pulm vascular congestion will be best managed by HD Consult Nephro, s/p HD 12/17   Poorly controlled hypertension BP as high as 213/90 Resume home meds As needed labetalol and hydralazine Outpatient follow-up   Anemia of chronic disease At baseline No active bleeding Monitor   Hyperlipidemia Continue statin   Schizoaffective disorder Continue Cogentin   GERD PPI
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperlipidaemia, Pulmonary congestion, SARS-CoV-2 test positive
Clinical narrative: The patient is a 68 y.o. female with history of ESRD, DM 2, bipolar 1, asthma, anemia, HTN, schizoaffective schizophrenia, presented to the medical center with cough.   Acute hypoxic respiratory failure Covid-19 Virus Infection Date of onset of symptoms: 12/9 Symptoms present on admission: Cough, shortness of breath Date of covid positive test: 12/12 Vaccination status: vaccinated Imaging: CXR shows pulmonary vascularcongestion Oxygen requirements on admission: Room air Current oxygen requirements: RA saturating 94-95% Medical therapy: Decadron x 10 days Anticipated special isolation end date: 12/20 if afebrile off antipyretics (not a candidate for short isolation as symptoms are not improving)    ESRD Pulmonary vascular congestion Hyperkalemia Is compliant with HD, most recent HD on day of admission Typically receives HD on T/R/S Patient is anuric, pulm vascular congestion will be best managed by HD Consult Nephro, s/p HD 12/17   Poorly controlled hypertension BP as high as 213/90 Resume home meds As needed labetalol and hydralazine Outpatient follow-up   Anemia of chronic disease At baseline No active bleeding Monitor   Hyperlipidemia Continue statin   Schizoaffective disorder Continue Cogentin   GERD PPI
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Diabetic ketoacidosis, Type 1 diabetes mellitus
Clinical narrative: Type 1 Diabetes
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus in both ears, more in left ear.  More bothersome/more noticeable at night and early morning.   was worse the first 6 months of 2022 but has decreased in intensity with time, but still exists even today.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: After administering vaccine, we were informed that the vaccine had experienced a temperature monitoring issue outside of our facility.  Per recommendation, patient informed and offered revaccination.  Received additional vaccination on 10/18/22.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: The patient was given the 3rd dose of COVID 19 Pfizer ( 6m-4 years) and this vaccine is no longer the one that should be given due to change to 2 doses of  COVID 19 Pfizer ( 6m-4 years and 3rd dose is the Bivalent dose
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Asthenia, Atrial fibrillation, COVID-19, Chest X-ray normal
Clinical narrative: Patient is a 87 yo female patient of PRIVATE, MD with history of afib, GERD, RLS presented to local Hospital with generalized weakness           Severe Hyponatremia 116 on admission-improved Possibly in the setting of SIADH likely from COVID-19 infection Patient urine osmolality 315, serum osmolality 236, urine sodium 55 Patient was on normal saline at 50 overnight with minimal change in serum sodium. Nephrology has been consulted. Patient may benefit from salt tablets and fluid restriction. Sodium at 125>>127>>131>>134   UTI: Patient UA concerning for infection.  Urine culture positive for Proteus species Continue IV ceftriaxone. Completed IV ceftriaxone therapy while in the hospital.   Hypotension: Resolved   Covid-19 Virus Infection Date of onset of symptoms: 12/10 Symptoms present on admission: Upper respiratory symptoms fever and diarrhea Date of covid positive test: 12/13 Vaccination status: vaccinated Imaging: cxr clear Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated Consultants following:  Anticipated special isolation end date: 12/20   Atrial fibrillation On digoxin and Xarelto and as needed flecainide   Restless leg syndrome Requip  GERD Pepcid   Diarrhea Resolved   Chronic fatigue disorder and generalized weakness PT/OT evaluation Physical therapy had recommended home health care, patient denies need for home health care and would be staying with her daughter.  Patient would reach out to her PCP if she needs home health care.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chronic fatigue syndrome, Culture urine positive, Diarrhoea, Hyponatraemia, Hypotension
Clinical narrative: Patient is a 87 yo female patient of PRIVATE, MD with history of afib, GERD, RLS presented to local Hospital with generalized weakness           Severe Hyponatremia 116 on admission-improved Possibly in the setting of SIADH likely from COVID-19 infection Patient urine osmolality 315, serum osmolality 236, urine sodium 55 Patient was on normal saline at 50 overnight with minimal change in serum sodium. Nephrology has been consulted. Patient may benefit from salt tablets and fluid restriction. Sodium at 125>>127>>131>>134   UTI: Patient UA concerning for infection.  Urine culture positive for Proteus species Continue IV ceftriaxone. Completed IV ceftriaxone therapy while in the hospital.   Hypotension: Resolved   Covid-19 Virus Infection Date of onset of symptoms: 12/10 Symptoms present on admission: Upper respiratory symptoms fever and diarrhea Date of covid positive test: 12/13 Vaccination status: vaccinated Imaging: cxr clear Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated Consultants following:  Anticipated special isolation end date: 12/20   Atrial fibrillation On digoxin and Xarelto and as needed flecainide   Restless leg syndrome Requip  GERD Pepcid   Diarrhea Resolved   Chronic fatigue disorder and generalized weakness PT/OT evaluation Physical therapy had recommended home health care, patient denies need for home health care and would be staying with her daughter.  Patient would reach out to her PCP if she needs home health care.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Proteus test positive, Pyrexia, Respiratory symptom, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Patient is a 87 yo female patient of PRIVATE, MD with history of afib, GERD, RLS presented to local Hospital with generalized weakness           Severe Hyponatremia 116 on admission-improved Possibly in the setting of SIADH likely from COVID-19 infection Patient urine osmolality 315, serum osmolality 236, urine sodium 55 Patient was on normal saline at 50 overnight with minimal change in serum sodium. Nephrology has been consulted. Patient may benefit from salt tablets and fluid restriction. Sodium at 125>>127>>131>>134   UTI: Patient UA concerning for infection.  Urine culture positive for Proteus species Continue IV ceftriaxone. Completed IV ceftriaxone therapy while in the hospital.   Hypotension: Resolved   Covid-19 Virus Infection Date of onset of symptoms: 12/10 Symptoms present on admission: Upper respiratory symptoms fever and diarrhea Date of covid positive test: 12/13 Vaccination status: vaccinated Imaging: cxr clear Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated Consultants following:  Anticipated special isolation end date: 12/20   Atrial fibrillation On digoxin and Xarelto and as needed flecainide   Restless leg syndrome Requip  GERD Pepcid   Diarrhea Resolved   Chronic fatigue disorder and generalized weakness PT/OT evaluation Physical therapy had recommended home health care, patient denies need for home health care and would be staying with her daughter.  Patient would reach out to her PCP if she needs home health care.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urine analysis abnormal, Urine osmolarity, Urine sodium normal
Clinical narrative: Patient is a 87 yo female patient of PRIVATE, MD with history of afib, GERD, RLS presented to local Hospital with generalized weakness           Severe Hyponatremia 116 on admission-improved Possibly in the setting of SIADH likely from COVID-19 infection Patient urine osmolality 315, serum osmolality 236, urine sodium 55 Patient was on normal saline at 50 overnight with minimal change in serum sodium. Nephrology has been consulted. Patient may benefit from salt tablets and fluid restriction. Sodium at 125>>127>>131>>134   UTI: Patient UA concerning for infection.  Urine culture positive for Proteus species Continue IV ceftriaxone. Completed IV ceftriaxone therapy while in the hospital.   Hypotension: Resolved   Covid-19 Virus Infection Date of onset of symptoms: 12/10 Symptoms present on admission: Upper respiratory symptoms fever and diarrhea Date of covid positive test: 12/13 Vaccination status: vaccinated Imaging: cxr clear Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated Consultants following:  Anticipated special isolation end date: 12/20   Atrial fibrillation On digoxin and Xarelto and as needed flecainide   Restless leg syndrome Requip  GERD Pepcid   Diarrhea Resolved   Chronic fatigue disorder and generalized weakness PT/OT evaluation Physical therapy had recommended home health care, patient denies need for home health care and would be staying with her daughter.  Patient would reach out to her PCP if she needs home health care.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Moderna Bivalent Booster 0.25mcg was given to patient, patient was to receive full dose 0.5mcg. Wrong dose given.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cognitive disorder, Computerised tomogram abnormal, Exercise tolerance decreased, Gait disturbance, Incontinence
Clinical narrative: Following the first booster in Aug, 2021, Patient began experiencing mobility issues and memory issues which worsened in the weeks following the first booster.    After the second booster, his  mobility issues worsened greatly to the point that he was unable to walk without assistance and had trouble with his cognitive skills and incontinence.  Over the following months, the symptoms continued to worsen and he developed neuropathy in his lower extremities.   Prior to taking the vaccines, he was an active, vibrant person with a sharp mind.  He ran 30 miles a week before the vaccines and was an active hiker and golfer.  He climbed mt. Kilimanjaro a few years earlier.   He is no longer capable of walking, much less running.   Minor symptoms began in the weeks following the original two vaccines in Feb. of 2021 but got much worse after the boosters.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture abnormal, Magnetic resonance imaging abnormal, Memory impairment, Mobility decreased, Neuropathy peripheral
Clinical narrative: Following the first booster in Aug, 2021, Patient began experiencing mobility issues and memory issues which worsened in the weeks following the first booster.    After the second booster, his  mobility issues worsened greatly to the point that he was unable to walk without assistance and had trouble with his cognitive skills and incontinence.  Over the following months, the symptoms continued to worsen and he developed neuropathy in his lower extremities.   Prior to taking the vaccines, he was an active, vibrant person with a sharp mind.  He ran 30 miles a week before the vaccines and was an active hiker and golfer.  He climbed mt. Kilimanjaro a few years earlier.   He is no longer capable of walking, much less running.   Minor symptoms began in the weeks following the original two vaccines in Feb. of 2021 but got much worse after the boosters.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Normal pressure hydrocephalus, Sepsis, Urinary tract infection
Clinical narrative: Following the first booster in Aug, 2021, Patient began experiencing mobility issues and memory issues which worsened in the weeks following the first booster.    After the second booster, his  mobility issues worsened greatly to the point that he was unable to walk without assistance and had trouble with his cognitive skills and incontinence.  Over the following months, the symptoms continued to worsen and he developed neuropathy in his lower extremities.   Prior to taking the vaccines, he was an active, vibrant person with a sharp mind.  He ran 30 miles a week before the vaccines and was an active hiker and golfer.  He climbed mt. Kilimanjaro a few years earlier.   He is no longer capable of walking, much less running.   Minor symptoms began in the weeks following the original two vaccines in Feb. of 2021 but got much worse after the boosters.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrioventricular block complete
Clinical narrative: 100% ARTERY BLOCKAGE.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Chills, Cough, Hypotension
Clinical narrative: COVID-19 symptoms: severe chills and shivering, fever 101.0, lack of energy, body aches. This lasted for a day and a half along with a moderate cough for 2 days. I have also have been unable to sleep post COVID-19 and have a lower than normal BP.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Insomnia, Pain, Pyrexia, SARS-CoV-2 test positive, Shift to the left
Clinical narrative: COVID-19 symptoms: severe chills and shivering, fever 101.0, lack of energy, body aches. This lasted for a day and a half along with a moderate cough for 2 days. I have also have been unable to sleep post COVID-19 and have a lower than normal BP.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given Moderna Bivalent Booster 0.25mcg, patient was to receive 0.5mcg. Wrong dose given
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dehydration, Enuresis, Glucose urine present, SARS-CoV-2 test positive
Clinical narrative: He did test positive for COVID-19 after a couple of days after being vaccinated. Symptoms started around May 2022. He lost 20 pounds within a month on a half. He had increased thirst, and it soon resulted to bed wetting and dehydration. The bed wetting happened around July. He was tested for glucose, and it was about 2000. He sent straight to the ER. They started him on insulin, and they found trace ketones. He was diagnosed with Type 1 insulin Independent Diabetes. He was in the hospital for one night.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Thirst, Type 1 diabetes mellitus, Urine analysis abnormal, Urine ketone body present, Weight decreased
Clinical narrative: He did test positive for COVID-19 after a couple of days after being vaccinated. Symptoms started around May 2022. He lost 20 pounds within a month on a half. He had increased thirst, and it soon resulted to bed wetting and dehydration. The bed wetting happened around July. He was tested for glucose, and it was about 2000. He sent straight to the ER. They started him on insulin, and they found trace ketones. He was diagnosed with Type 1 insulin Independent Diabetes. He was in the hospital for one night.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Exposure to SARS-CoV-2, Hepatic enzyme increased, Malaise
Clinical narrative: I was exposed to COVID-19 on 01/09/2022. I started having symptoms on 01/10/2022 and I continued to work. I had a fever, chills and body aches. I was taking a lot of preventative supplements at that time and did not receive a prescription. I previously tested positive for COVID-19 on 08/04/2022 and on 11/07/2022. After my November COVID-19 infection, I have elevated liver enzymes since having COVID-19. As of today, my liver enzymes have improved but are not in normal range.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I was exposed to COVID-19 on 01/09/2022. I started having symptoms on 01/10/2022 and I continued to work. I had a fever, chills and body aches. I was taking a lot of preventative supplements at that time and did not receive a prescription. I previously tested positive for COVID-19 on 08/04/2022 and on 11/07/2022. After my November COVID-19 infection, I have elevated liver enzymes since having COVID-19. As of today, my liver enzymes have improved but are not in normal range.
Age: 78.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: COVID-19, Decreased appetite, Fatigue, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: I had a runny nose and a mild sore throat and I was tired. I was also living with someone who tested positive for COVID-19. Not much of an appetite. May be due to prior to COVID-19 or the PAXLOVID.
Age: 78.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a runny nose and a mild sore throat and I was tired. I was also living with someone who tested positive for COVID-19. Not much of an appetite. May be due to prior to COVID-19 or the PAXLOVID.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: After giving the Pfizer vaccine, were notified that the vaccine had experienced a temperature monitoring event outside of our facility.  The patient and his family were called and informed of the CDC recommendations.  Returned for additional vaccination on 10/19/22.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: After giving the Pfizer vaccine, were notified that the vaccine had experienced a temperature monitoring event outside of our facility.  The patient and his family were called and informed of the CDC recommendations.  The patient came in to receive an addition vaccine on 10/12/2022
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: After giving the Pfizer vaccine, were notified that the vaccine had experienced a temperature monitoring event outside of our facility.  The patient and his family were called and informed of the recommendations.  The patient came in to receive an addition vaccine on 10//12/2022.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chills
Clinical narrative: chills
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: After giving the Pfizer vaccine, were notified that the vaccine had experienced a temperature monitoring event outside of our facility.  The patient and his family were called and informed of the recommendations.  The patient declined revaccination.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Headache, Nasal congestion, Rhinorrhoea
Clinical narrative: I had a headache, nasal congestion, nasal discharge, and mild cough. I tested positive for COVID-19 at the doctor's office on 12/23/2022. They prescribed me PAXLOVID and benzonatate. A week later after completed PAXLOVID my symptoms came back and tested positive again for COVID-19. I had the exact same symptoms.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a headache, nasal congestion, nasal discharge, and mild cough. I tested positive for COVID-19 at the doctor's office on 12/23/2022. They prescribed me PAXLOVID and benzonatate. A week later after completed PAXLOVID my symptoms came back and tested positive again for COVID-19. I had the exact same symptoms.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fall, Glycosylated haemoglobin normal, Pathological fracture, Radius fracture
Clinical narrative: Patient is a 76 y.o. female patient of, MD with history of diabetes, hypertension, hyperlipidemia, COPD, diastolic congestive heart failure, obesity presented to Hospital with fall with left distal radius fracture.   HHC set up  follow up to ID and Orthopedic.    Fall with left distal radius fracture Pathological fracture of left distal radius due to a combination of osteopenia and trauma that alone would not have caused the fracture Ortho consult-recommend nonoperative management Continue splint and pain control Outpatient follow-up with orthopedic surgeon     Covid-19 Virus Infection Date of onset of symptoms: 12/10/22 Symptoms present on admission: No Date of covid positive test: 12/10/22 Vaccination status: vaccinated Imaging: None Oxygen requirements on admission: None Current oxygen requirements: 2 L (home baseline) Medical therapy: Start steroids Consultants following: ID consulted Anticipated special isolation end date: 12/20/22 ID following on pavloxivoid.    Type 2 diabetes Last A1c 6.2 in 10/2022 Continue Lantus plus sliding scale Adjust insulin accordingly   Hypertension Continue home meds   Hyperlipidemia Continue statin  History of diastolic CHF Continue Lasix Aldactone   History of COPD Continue with home inhaler Supportive care
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient is a 76 y.o. female patient of, MD with history of diabetes, hypertension, hyperlipidemia, COPD, diastolic congestive heart failure, obesity presented to Hospital with fall with left distal radius fracture.   HHC set up  follow up to ID and Orthopedic.    Fall with left distal radius fracture Pathological fracture of left distal radius due to a combination of osteopenia and trauma that alone would not have caused the fracture Ortho consult-recommend nonoperative management Continue splint and pain control Outpatient follow-up with orthopedic surgeon     Covid-19 Virus Infection Date of onset of symptoms: 12/10/22 Symptoms present on admission: No Date of covid positive test: 12/10/22 Vaccination status: vaccinated Imaging: None Oxygen requirements on admission: None Current oxygen requirements: 2 L (home baseline) Medical therapy: Start steroids Consultants following: ID consulted Anticipated special isolation end date: 12/20/22 ID following on pavloxivoid.    Type 2 diabetes Last A1c 6.2 in 10/2022 Continue Lantus plus sliding scale Adjust insulin accordingly   Hypertension Continue home meds   Hyperlipidemia Continue statin  History of diastolic CHF Continue Lasix Aldactone   History of COPD Continue with home inhaler Supportive care
Age: 75.0
Sex: F
Vaccine: UNK
Symptoms: Product storage error
Clinical narrative: After giving the Pfizer vaccine, were notified that the vaccine had experienced a temperature monitoring event outside of our facility.  The patient and his family were called and informed of the CDC recommendations.  The patient came in to receive an addition vaccine on 10/18/22.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Incorrect product formulation administered
Clinical narrative: PT presented to clinic today for COVID Pfizer vaccine.  Data confirmed Pfizer primary dose given on 10/6/21 @ Pharmacy.  Pfizer # 2 Primary drawn up.    PT greeted and to exam room.  PT asked about concerns over vaccines due to the length of time to get her second Pfizer primary.  PT presents a vaccine card stating this would be her second booster dose.  PT states she is pregnant at six months.  PT asked about pregnancy concerns, advised there are no contraindications and CDC recommends Covid vaccination for pregnant women.  PT also asked about side effects as she usually gets a fever with her Pfizer shots.  I explained side effects to PT and confirmed Fever is one.  I suggested considering a Moderna booster in the future as mixing vaccine brands adds a small increase in protection and she may experience less side effects or more, but worth considering.  PT agrees to move forward with Pfizer vaccine.   Patient tolerated well without any adverse reactions.  PT advised to wait in lobby for 15 mins, drink plenty of water and no physical exertion rest of day.   As I was filling out the PT card, I realized I had given her a Pfizer primary dose, and not the Pfizer bivalent booster.  I reported my mistake to my Manager.  Manager confirmed on CDC the PT should return to facility in 2 months for the Covid bivalent booster.   I asked the PT to return to the exam room with me.  I explained to the PT that I had made a mistake of giving her the Pfizer primary and she should have been given a Pfizer bivalent.  I sincerely apologized for my error and asked if she wanted to speak with my boss.  PT said no, asked if there was a need for concern.  I explained CDC information that PT will be fine, and should return in two months for bivalent booster.   PT asked if her baby would be ok.  I said yes, antibodies would be passed to the baby.  PT was calm and relaxed, but I again offered if she would like to speak with my boss.  No, she understood mistakes happen.  I again reiterated how truly sorry I was.  I gave the PT Facility phone number, Manager's name and my name if she need to callback and ask questions.  PT monitored for 15 minutes post vaccine administration, no s/s reported, no further questions.  Pt contacted OB.  OB confirmed PT and baby will be ok.  To PCP Dr as FYI.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Death, Echocardiogram abnormal, Ejection fraction normal, General physical health deterioration
Clinical narrative: The patient was an unfortunate 68-year-old white female with very complicated medical history, who was initially admitted to hospital on December 13th, for respiratory failure and altered mental status.  ABG revealed a severe respiratory acidosis.  She was intubated immediately.  She had a prolonged complicated hospital course significant for severe sepsis with shock, pneumonia, acute on chronic kidney disease, congestive heart failure, and possible C difficile colitis.  She received broad-spectrum antibiotics.  Efforts at ventilator weaning were unsuccessful.  She was then transferred to facility on December 29th.  An echocardiogram revealed an ejection fraction of around 60%.  Moderate right ventricle enlargement.  Mildly decreased right ventricular systolic function.  Estimated systolic pulmonary artery pressure of 61.  Severe right atrial enlargement.  2+ MR and moderate PR.  She underwent diuresis.  Empiric antibiotics were resumed.  Unfortunately, she steadily clinically worsened.  Renal function worsened and she began to struggle with hyperkalemia.  She was largely maxed out on ventilator support.  She was continued on cyclosporine.  Heparin drip was provided for anticoagulation given her atrial fibrillation.    Given her multiple medical issues, poor prognosis, and clinical deterioration, had an extensive discussion with her son.  Code status was made DNR and care was withdrawn.  She was comfortable.  She was extubated and pronounced dead at 1:22 on January 5, 2023.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperkalaemia, Mitral valve incompetence, Pulmonary valve incompetence, Renal impairment, Right atrial enlargement
Clinical narrative: The patient was an unfortunate 68-year-old white female with very complicated medical history, who was initially admitted to hospital on December 13th, for respiratory failure and altered mental status.  ABG revealed a severe respiratory acidosis.  She was intubated immediately.  She had a prolonged complicated hospital course significant for severe sepsis with shock, pneumonia, acute on chronic kidney disease, congestive heart failure, and possible C difficile colitis.  She received broad-spectrum antibiotics.  Efforts at ventilator weaning were unsuccessful.  She was then transferred to facility on December 29th.  An echocardiogram revealed an ejection fraction of around 60%.  Moderate right ventricle enlargement.  Mildly decreased right ventricular systolic function.  Estimated systolic pulmonary artery pressure of 61.  Severe right atrial enlargement.  2+ MR and moderate PR.  She underwent diuresis.  Empiric antibiotics were resumed.  Unfortunately, she steadily clinically worsened.  Renal function worsened and she began to struggle with hyperkalemia.  She was largely maxed out on ventilator support.  She was continued on cyclosporine.  Heparin drip was provided for anticoagulation given her atrial fibrillation.    Given her multiple medical issues, poor prognosis, and clinical deterioration, had an extensive discussion with her son.  Code status was made DNR and care was withdrawn.  She was comfortable.  She was extubated and pronounced dead at 1:22 on January 5, 2023.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Right ventricular dysfunction, Right ventricular enlargement
Clinical narrative: The patient was an unfortunate 68-year-old white female with very complicated medical history, who was initially admitted to hospital on December 13th, for respiratory failure and altered mental status.  ABG revealed a severe respiratory acidosis.  She was intubated immediately.  She had a prolonged complicated hospital course significant for severe sepsis with shock, pneumonia, acute on chronic kidney disease, congestive heart failure, and possible C difficile colitis.  She received broad-spectrum antibiotics.  Efforts at ventilator weaning were unsuccessful.  She was then transferred to facility on December 29th.  An echocardiogram revealed an ejection fraction of around 60%.  Moderate right ventricle enlargement.  Mildly decreased right ventricular systolic function.  Estimated systolic pulmonary artery pressure of 61.  Severe right atrial enlargement.  2+ MR and moderate PR.  She underwent diuresis.  Empiric antibiotics were resumed.  Unfortunately, she steadily clinically worsened.  Renal function worsened and she began to struggle with hyperkalemia.  She was largely maxed out on ventilator support.  She was continued on cyclosporine.  Heparin drip was provided for anticoagulation given her atrial fibrillation.    Given her multiple medical issues, poor prognosis, and clinical deterioration, had an extensive discussion with her son.  Code status was made DNR and care was withdrawn.  She was comfortable.  She was extubated and pronounced dead at 1:22 on January 5, 2023.
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Moderna Bivalent Booster 0.25mcg was given to patient, was to be given 0.5mcg. Wrong dose given.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Ear discomfort, Head discomfort, Otorrhoea, SARS-CoV-2 test positive
Clinical narrative: Started as fullness and heaviness in both ears occasionally during first two months after second shot. Since then, both ears have fullness and heaviness most of the time in varying durations, including ear popping and ear ringing. Both ears occasionally feel wet inside. Clear, water-like fluid occasionally comes out of both ears. Tested positive for COVID on Jan 2, 2023. Since then, have had EXTREME head pressure and increased ear fullness and heaviness.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Started as fullness and heaviness in both ears occasionally during first two months after second shot. Since then, both ears have fullness and heaviness most of the time in varying durations, including ear popping and ear ringing. Both ears occasionally feel wet inside. Clear, water-like fluid occasionally comes out of both ears. Tested positive for COVID on Jan 2, 2023. Since then, have had EXTREME head pressure and increased ear fullness and heaviness.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Atelectasis, Blood lactic acid decreased, Blood magnesium normal
Clinical narrative: Patient is a 83 y.o. female patient of, MD with history of COVID 19 ( 12/11/22), DM, HTN  presented to Hospital with nausea, emesis, and diarrhea   Hyponatremia Secondary to dehydration from vomiting / COVID  Corrected sodium on admission 124 Patient was given 1 L NS bolus in ED BMP every 6 hours 12/14/22 Na+ 122. Stop hydrochlorothiazide and spirolactone  Ur osm 360, Ur Na 46 Ser Osm 272 0.9NS at 75cc/hr completed Na fluctuating 126 (12/18/22), not much improvement with IV hydration. Added salt tabs  Continue salt tabs. Na improving 130 12/19 => 134 12/20 TSH nl Will check bmp in 1 week   COVID-19 Infection Generalized weakness   Symptoms onset 12/9/22, positive test date 12/11/22 No current oxygen demand Continue paxlovid Anticoagulation: Heparin SQ Consider discontinuation of isolation 12/21/22 PT recommended intensity of skilled Therapy5 to 7 days per week/Duration 10 - 30 days. Swing bed likely 12/20   Sepsis without organ dysfunction - resolved Secondary to  COVID-19 and possible left lower lobe PNA  & POA Presented with tachycardia and leukocytosis. QSOFA score 0 Hemodynamically stable, not requiring vasopressors. Lactic acid 2.0 Pro calc nl Received  1 L NS bolus  in ED.  Workup: CXR with left lower lobe atelectasis and/or airspace disease Blood cultures NGTD urine culture neg Completed Ceftriaxone and azithromycin.    Hypokalemia-resolved  3.1 on presentation Magnesium 1.6 Replace and recheck K of 4.1 (12/18)  DM2 with hyperglycemia Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180 Added Lantus 30 units (12/18) titrate based on BG Continue home meds   HTN  Elevated blood pressure Continue nifedipine, clonidine, and aldactone   Constipation - resolved Reports no BM since admission Added schedule laxative and senna s
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Blood osmolarity decreased, Blood potassium decreased, Blood sodium decreased, COVID-19, Chest X-ray abnormal
Clinical narrative: Patient is a 83 y.o. female patient of, MD with history of COVID 19 ( 12/11/22), DM, HTN  presented to Hospital with nausea, emesis, and diarrhea   Hyponatremia Secondary to dehydration from vomiting / COVID  Corrected sodium on admission 124 Patient was given 1 L NS bolus in ED BMP every 6 hours 12/14/22 Na+ 122. Stop hydrochlorothiazide and spirolactone  Ur osm 360, Ur Na 46 Ser Osm 272 0.9NS at 75cc/hr completed Na fluctuating 126 (12/18/22), not much improvement with IV hydration. Added salt tabs  Continue salt tabs. Na improving 130 12/19 => 134 12/20 TSH nl Will check bmp in 1 week   COVID-19 Infection Generalized weakness   Symptoms onset 12/9/22, positive test date 12/11/22 No current oxygen demand Continue paxlovid Anticoagulation: Heparin SQ Consider discontinuation of isolation 12/21/22 PT recommended intensity of skilled Therapy5 to 7 days per week/Duration 10 - 30 days. Swing bed likely 12/20   Sepsis without organ dysfunction - resolved Secondary to  COVID-19 and possible left lower lobe PNA  & POA Presented with tachycardia and leukocytosis. QSOFA score 0 Hemodynamically stable, not requiring vasopressors. Lactic acid 2.0 Pro calc nl Received  1 L NS bolus  in ED.  Workup: CXR with left lower lobe atelectasis and/or airspace disease Blood cultures NGTD urine culture neg Completed Ceftriaxone and azithromycin.    Hypokalemia-resolved  3.1 on presentation Magnesium 1.6 Replace and recheck K of 4.1 (12/18)  DM2 with hyperglycemia Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180 Added Lantus 30 units (12/18) titrate based on BG Continue home meds   HTN  Elevated blood pressure Continue nifedipine, clonidine, and aldactone   Constipation - resolved Reports no BM since admission Added schedule laxative and senna s
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Constipation, Culture urine negative, Dehydration, Diarrhoea
Clinical narrative: Patient is a 83 y.o. female patient of, MD with history of COVID 19 ( 12/11/22), DM, HTN  presented to Hospital with nausea, emesis, and diarrhea   Hyponatremia Secondary to dehydration from vomiting / COVID  Corrected sodium on admission 124 Patient was given 1 L NS bolus in ED BMP every 6 hours 12/14/22 Na+ 122. Stop hydrochlorothiazide and spirolactone  Ur osm 360, Ur Na 46 Ser Osm 272 0.9NS at 75cc/hr completed Na fluctuating 126 (12/18/22), not much improvement with IV hydration. Added salt tabs  Continue salt tabs. Na improving 130 12/19 => 134 12/20 TSH nl Will check bmp in 1 week   COVID-19 Infection Generalized weakness   Symptoms onset 12/9/22, positive test date 12/11/22 No current oxygen demand Continue paxlovid Anticoagulation: Heparin SQ Consider discontinuation of isolation 12/21/22 PT recommended intensity of skilled Therapy5 to 7 days per week/Duration 10 - 30 days. Swing bed likely 12/20   Sepsis without organ dysfunction - resolved Secondary to  COVID-19 and possible left lower lobe PNA  & POA Presented with tachycardia and leukocytosis. QSOFA score 0 Hemodynamically stable, not requiring vasopressors. Lactic acid 2.0 Pro calc nl Received  1 L NS bolus  in ED.  Workup: CXR with left lower lobe atelectasis and/or airspace disease Blood cultures NGTD urine culture neg Completed Ceftriaxone and azithromycin.    Hypokalemia-resolved  3.1 on presentation Magnesium 1.6 Replace and recheck K of 4.1 (12/18)  DM2 with hyperglycemia Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180 Added Lantus 30 units (12/18) titrate based on BG Continue home meds   HTN  Elevated blood pressure Continue nifedipine, clonidine, and aldactone   Constipation - resolved Reports no BM since admission Added schedule laxative and senna s
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperglycaemia, Hypokalaemia, Hyponatraemia, Leukocytosis, Lung disorder
Clinical narrative: Patient is a 83 y.o. female patient of, MD with history of COVID 19 ( 12/11/22), DM, HTN  presented to Hospital with nausea, emesis, and diarrhea   Hyponatremia Secondary to dehydration from vomiting / COVID  Corrected sodium on admission 124 Patient was given 1 L NS bolus in ED BMP every 6 hours 12/14/22 Na+ 122. Stop hydrochlorothiazide and spirolactone  Ur osm 360, Ur Na 46 Ser Osm 272 0.9NS at 75cc/hr completed Na fluctuating 126 (12/18/22), not much improvement with IV hydration. Added salt tabs  Continue salt tabs. Na improving 130 12/19 => 134 12/20 TSH nl Will check bmp in 1 week   COVID-19 Infection Generalized weakness   Symptoms onset 12/9/22, positive test date 12/11/22 No current oxygen demand Continue paxlovid Anticoagulation: Heparin SQ Consider discontinuation of isolation 12/21/22 PT recommended intensity of skilled Therapy5 to 7 days per week/Duration 10 - 30 days. Swing bed likely 12/20   Sepsis without organ dysfunction - resolved Secondary to  COVID-19 and possible left lower lobe PNA  & POA Presented with tachycardia and leukocytosis. QSOFA score 0 Hemodynamically stable, not requiring vasopressors. Lactic acid 2.0 Pro calc nl Received  1 L NS bolus  in ED.  Workup: CXR with left lower lobe atelectasis and/or airspace disease Blood cultures NGTD urine culture neg Completed Ceftriaxone and azithromycin.    Hypokalemia-resolved  3.1 on presentation Magnesium 1.6 Replace and recheck K of 4.1 (12/18)  DM2 with hyperglycemia Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180 Added Lantus 30 units (12/18) titrate based on BG Continue home meds   HTN  Elevated blood pressure Continue nifedipine, clonidine, and aldactone   Constipation - resolved Reports no BM since admission Added schedule laxative and senna s
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Nausea, Procalcitonin normal, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient is a 83 y.o. female patient of, MD with history of COVID 19 ( 12/11/22), DM, HTN  presented to Hospital with nausea, emesis, and diarrhea   Hyponatremia Secondary to dehydration from vomiting / COVID  Corrected sodium on admission 124 Patient was given 1 L NS bolus in ED BMP every 6 hours 12/14/22 Na+ 122. Stop hydrochlorothiazide and spirolactone  Ur osm 360, Ur Na 46 Ser Osm 272 0.9NS at 75cc/hr completed Na fluctuating 126 (12/18/22), not much improvement with IV hydration. Added salt tabs  Continue salt tabs. Na improving 130 12/19 => 134 12/20 TSH nl Will check bmp in 1 week   COVID-19 Infection Generalized weakness   Symptoms onset 12/9/22, positive test date 12/11/22 No current oxygen demand Continue paxlovid Anticoagulation: Heparin SQ Consider discontinuation of isolation 12/21/22 PT recommended intensity of skilled Therapy5 to 7 days per week/Duration 10 - 30 days. Swing bed likely 12/20   Sepsis without organ dysfunction - resolved Secondary to  COVID-19 and possible left lower lobe PNA  & POA Presented with tachycardia and leukocytosis. QSOFA score 0 Hemodynamically stable, not requiring vasopressors. Lactic acid 2.0 Pro calc nl Received  1 L NS bolus  in ED.  Workup: CXR with left lower lobe atelectasis and/or airspace disease Blood cultures NGTD urine culture neg Completed Ceftriaxone and azithromycin.    Hypokalemia-resolved  3.1 on presentation Magnesium 1.6 Replace and recheck K of 4.1 (12/18)  DM2 with hyperglycemia Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180 Added Lantus 30 units (12/18) titrate based on BG Continue home meds   HTN  Elevated blood pressure Continue nifedipine, clonidine, and aldactone   Constipation - resolved Reports no BM since admission Added schedule laxative and senna s